Trials / Terminated
TerminatedNCT01021176
Evaluate a Medication on How Hunger and Appetite Are Influenced by Smell
A Single Dose Pilot Study to Evaluate the Safety and Dose-Response of Smell to Intranasal Diltiazem
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Pennington Biomedical Research Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether the blood pressure medication, diltiazem, will temporarily decrease the sense of smell when given in a nasal spray which will then reduce food intake.
Detailed description
You will fast on your first visit. Complete questionnaire about taste and smell to insure you don't have a cold or anything that would interfere with sense of smell. Your nose will be checked. Blood pressure taken, and administer to you a spray with diltiazem 2, 4, 8 mg or a placebo. Your sense of smell will be tested at different time points.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Placebo spray | 0, 30, 60, 90, 120, 180, and 240 minutes following the nasal spray yet no drug will be administered |
| DRUG | Diltiazem | 0, 30, 60, 90, 120, 180, and 240 minutes following the nasal spray Three Dilutions would be 5.5, 6.0 and 6.3 and the fourth at the filp of a coin randomly diluted. |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2009-11-26
- Last updated
- 2015-12-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01021176. Inclusion in this directory is not an endorsement.